Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PT Siloam International Hospitals Tbk EV-to-OCF?
PT Siloam International Hospitals TbkFRA:2LS 88 EV-to-OCF is 12.38 as of Aug. 11, 2026, which is 14% below its 10-year median of 14.47. GuruFocus rates FRA:2LS with a GF Score™ of 88/100 and a GF Value™ of €0.12. The stock has 1 warning sign investors should review. Among 681 Healthcare Providers & Services companies, PT Siloam International Hospitals Tbk ranks worse than 62.85% on this metric.
FRA:2LS'
s EV-to-OCF Range Over the Past 10 Years
Min: -747.55 Med: 14.47 Max: 104.96
Current: 12.98
During the past 13 years, the highest EV-to-OCF of PT Siloam International Hospitals Tbk was 104.96. The lowest was -747.55. And the median was 14.47.
FRA:2LS's EV-to-OCF is ranked worse than 62.85% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 8.95
vs FRA:2LS: 12.98
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Siloam International Hospitals Tbk (FRA:2LS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Siloam International Hospitals Tbk's PE Ratio (TTM) for today is calculated as:
PT Siloam International Hospitals Tbk's share price for today is €0.105.
PT Siloam International Hospitals Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.004.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Siloam International Hospitals Tbk EV-to-OCF Related Terms
PT Siloam International Hospitals Tbk EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk EV-to-OCF Chart
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's EV-to-OCF falls into.
PT Siloam International Hospitals Tbk's current Enterprise Value is €1,561.1 Mil.
PT Siloam International Hospitals Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €126.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk (FRA:2LS) has a EV-to-OCF of 12.38 as of Aug. 11, 2026. This is 14% below median its historical median of 14.47. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #428 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 62.8%.
Is PT Siloam International Hospitals Tbk's EV-to-OCF too high?
PT Siloam International Hospitals Tbk's current EV-to-OCF of 12.38 is 14% below median its 10-year median of 14.47. The Healthcare Providers & Services industry median EV-to-OCF is 8.95. PT Siloam International Hospitals Tbk's value of 12.38 is 38.3% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #428 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #428 out of 681 companies for EV-to-OCF. This places PT Siloam International Hospitals Tbk in the lower half of its industry. The industry median EV-to-OCF is 8.95. PT Siloam International Hospitals Tbk's value of 12.38 is 38.3% above this benchmark. While the company's 10-year median is 14.47 vs. the industry median of 8.95, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current EV-to-OCF of 12.38 is 38.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current EV-to-OCF is 12.38, which is 14% below median its own 10-year median of 14.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current EV-to-OCF of 12.38. The stock's GF Value™ is €0.12, compared to a current price of €0.11 — trading 12.5% below its estimated fair value. The current EV-to-OCF is 12.38, which is 14% below median its 10-year median of 14.47 and 38.3% above the Healthcare Providers & Services industry median of 8.95. PT Siloam International Hospitals Tbk's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current EV-to-OCF is 12.38 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.11 is trading 12.5% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:2LS:
EV-to-OCF: 12.38 (14% below median its 10-year median of 14.47)
GF Value™: €0.12 vs. price of €0.11 (12.5% below fair value)
Industry Position: 38.3% above the Healthcare Providers & Services median (#428 of 681)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
88GF Score
Get the complete analysis for FRA:2LS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
